Skandinaviska Enskilda Banken AB publ recently reduced its stake in ResMed Inc. by 36.6%, selling 49,690 shares but still maintaining holdings worth $23.55 million. Meanwhile, ResMed exceeded quarterly earnings expectations with strong revenue growth and declared a $0.60 quarterly dividend. The company also saw significant insider selling, including shares sold by its CEO, despite analysts maintaining a “Moderate Buy” consensus rating.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Skandinaviska Enskilda Banken AB publ Has $23.55 Million Stock Holdings in ResMed Inc. $RMD
Skandinaviska Enskilda Banken AB publ recently reduced its stake in ResMed Inc. by 36.6%, selling 49,690 shares but still maintaining holdings worth $23.55 million. Meanwhile, ResMed exceeded quarterly earnings expectations with strong revenue growth and declared a $0.60 quarterly dividend. The company also saw significant insider selling, including shares sold by its CEO, despite analysts maintaining a “Moderate Buy” consensus rating.